Counterfeit retatrutide linked to torn oesophagus, officials warn
Authorities issued a fresh warning after a patient was injured by an unapproved drug sold as retatrutide.
DO
By Daniel Okafor · Regulatory Correspondent
Sep 15 04:18 ETSource: 7NEWS
The wire
- 01A patient suffered a torn oesophagus after using a counterfeit product marketed as retatrutide.
- 02Highlights safety risks of grey-market peptides sold as unapproved obesity drugs.
- 03Source of the counterfeit product and enforcement actions are not detailed.
From the source
Read at news.google.comFresh warning after patient suffers torn oesophagus from counterfeit drug sold as retatrutide